Matsumoto, H.; Suzuki, H.; Yamanaka, T.; Kaiho, T.; Hata, A.; Inage, T.; Ito, T.; Kamata, T.; Tanaka, K.; Sakairi, Y.;
et al. Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation. Life 2023, 13, 2042.
https://doi.org/10.3390/life13102042
AMA Style
Matsumoto H, Suzuki H, Yamanaka T, Kaiho T, Hata A, Inage T, Ito T, Kamata T, Tanaka K, Sakairi Y,
et al. Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation. Life. 2023; 13(10):2042.
https://doi.org/10.3390/life13102042
Chicago/Turabian Style
Matsumoto, Hiroki, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Atsushi Hata, Terunaga Inage, Takamasa Ito, Toshiko Kamata, Kazuhisa Tanaka, Yuichi Sakairi,
and et al. 2023. "Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation" Life 13, no. 10: 2042.
https://doi.org/10.3390/life13102042
APA Style
Matsumoto, H., Suzuki, H., Yamanaka, T., Kaiho, T., Hata, A., Inage, T., Ito, T., Kamata, T., Tanaka, K., Sakairi, Y., Motohashi, S., & Yoshino, I.
(2023). Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation. Life, 13(10), 2042.
https://doi.org/10.3390/life13102042